“Synthesis and Characterization of YYGSR-NH2 as a Chemical Starting Poin for Thyroid Theranostic Radiopharmaceutical Development” (2026) JURNAL FARMASIMED (JFM), 9(1), pp. 830–841. doi:10.35451/jfm.v9i1.3856.